Skip to main content

Day: January 3, 2022

Altra Completes Acquisition of Nook Industries, a Leader in the US Engineered Linear Motion Industry

Deal Advances Strategy to Focus on Highly Engineered Products in the Motion Control and Power Transmission Markets and Expands Presence in Attractive Medical, Factory Automation and Defense Markets Expects Acquisition to be Cash Accretive in 2022, Excluding Transaction Costs BRAINTREE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) — Altra Industrial Motion Corp. (Nasdaq: AIMC) (“Altra” or the “Company”), a leading global manufacturer and supplier of motion control, power transmission and automation products, today announced that it has acquired Cleveland, Ohio-based Nook Industries LLC (“Nook”), a leader in the US engineered linear motion industry. Nook is expected to generate approximately $42 million in revenue in 2021, and the transaction is anticipated to be cash accretive to Altra’s earnings in 2022, excluding any one-time or acquisition-related...

Continue reading

Apollo Completes Merger with Athene and Finalizes Key Governance Enhancements

Fully Aligned and Capital Efficient Model Positions Apollo for Differentiated Growth and Returns Enhanced Liquidity and Trading Profile Expected to Attract Broader, More Diversified Investor Base NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) — Apollo and Athene today announced the successful completion of their merger under Apollo Global Management, Inc. (NYSE: APO), a high-growth alternative asset manager with asset management and retirement services capabilities. “Apollo and Athene are world-class franchises that have flourished as strategic partners, and we expect the full alignment achieved by our merger will accelerate our collective growth,” said Apollo CEO Marc Rowan. “I am thrilled to partner with experienced leaders and talented teams within both businesses that will drive our differentiated ‘One Apollo’ model forward. Together,...

Continue reading

Mondelēz International Completes Acquisition of Chipita Global S.A., High-Growth European Leader in Croissants and Baked Snacks

Represents important milestone in Company’s strategy to accelerate growth and become a global snacking leader Enhances offering in attractive $65B global packaged baked snacks category Enables innovation across beloved brands including Cadbury, Milka and 7DaysCHICAGO, Jan. 03, 2022 (GLOBE NEWSWIRE) — Mondelēz International, Inc. (Nasdaq: MDLZ) today announced that it has completed the acquisition of Chipita Global S.A., a high-growth leader in the Central and Eastern European croissants and baked snacks category. The acquisition marks an exciting milestone in the Company’s strategic plan, focused on accelerating growth in core snacking adjacencies, while continuing to expand its footprint in key markets. Established in Greece more than 40 years ago, Chipita S.A. delivers croissants and other baked snack brands to two billion...

Continue reading

AKVA group ASA: Financial calendar

Financial calendar for AKVA group ASA FINANCIAL YEAR 2021 16.03.2022 – Annual Report 11.02.2022 – Quarterly Report – Q4 FINANCIAL YEAR 2022 12.08.2022 – Half-yearly Report12.05.2022 – Annual General Meeting 13.05.2022 – Quarterly Report – Q104.11.2022 – Quarterly Report – Q3Dated: 3 January 2022AKVA group ASA Web: www.akvagroup.com CONTACTS:Knut Nesse Chief Executive OfficerPhone: +47 51 77 85 00Mobile: +47 91 37 62 20E-mail: knesse@akvagroup.comRonny Meinkøhn Chief Financial OfficerPhone: +47 51 77 85 00Mobile: +47 98 20 67 76E-mail: rmeinkohn@akvagroup.comThis information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Continue reading

Brown & Brown, Inc. announces the asset acquisition of HARCO Insurance Services and HARCO Financial Services

DAYTONA BEACH, Fla., Jan. 03, 2022 (GLOBE NEWSWIRE) — J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE: BRO), and Christopher (“Chris”) L. Goff, Willis (“Josh”) J. Hargrave, III, and Geraldeen (“Gerri”) Rougeau-Eubank, the principals of HARCO Insurance Services, Inc. d/b/a HARCO Insurance Services and Lone Star Affiliates, Inc. d/b/a HARCO Financial Services (collectively, “HARCO”), today announced that Brown & Brown Lone Star Insurance Services, Inc., a subsidiary of Brown & Brown, Inc., has acquired substantially all of the assets of HARCO. With roots dating back to 1969, HARCO is a full-service, independent retail insurance agency serving businesses and individuals throughout Texas. Following the acquisition, the HARCO team will continue operating from their existing Houston, Texas office...

Continue reading

Beam Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 2:15 p.m. ET. A live webcast will be available in the investor section of the company’s website at www.beamtx.com, and will be archived for 60 days following the presentation. About Beam TherapeuticsBeam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building...

Continue reading

Verve Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 4:30 p.m. ET. A live webcast will be available in the investor section of the company’s website at www.vervetx.com. The webcast will be archived for 60 days following the presentation. About Verve Therapeutics Verve Therapeutics, Inc. (Nasdaq: VERV) is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company’s initial...

Continue reading

Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators

Exclusive license from AstraZeneca adds a unique candidate and a broad library of compounds to Ovid’s franchise of potential first-in-class anti-epileptic therapiesCollaboration with Dr. Stephen Moss, founder of Tufts Laboratory for Basic and Translational Neuroscience Research, and expert team in neuropharmacologyTransaction is the first business development activity that seeks to enhance Ovid’s pipeline of small-molecule and genetic CNS medicinesNEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced the company has entered into an exclusive license agreement with AstraZeneca for a library of early-stage small molecules targeting the KCC2 transporter,...

Continue reading

Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that the company will participate in a pre-recorded presentation at the H.C. Wainwright BIOCONNECT Virtual Conference. The presentation will be available on the conference website beginning at 7 a.m. Eastern / 4 a.m. Pacific on January 10, 2022. A link to the presentation will also be available at the same time in the Investors section of the company’s website at progenity.com/presentations. About Progenity Progenity, Inc. is a biotechnology company innovating in the fields of women’s health, gastrointestinal health and oral biotherapeutics. Progenity applies a multi-omics approach, combining genomics, epigenomics, proteomics,...

Continue reading

Green Energy Group (SeaBird Exploration Plc): Extraordinary General Meeting completed

3 January 2022, Limassol, Cyprus An Extraordinary General Meeting (the “EGM”) in SeaBird Exploration Plc was held on 31 December 2021. All items on the agenda as set out in the notice of the meeting announced on 16 December 2021 were adopted. Please find attached the minutes from the EGM. For further queries contact: Erik von Krogh CFO Mob: +47 930 38 075 All statements in this press release other than statements of historical fact are forward-looking statements and are subject to a number of risks, uncertainties and assumptions that are difficult to predict, and are based upon assumptions as to future events that may not prove accurate. These factors include SeaBird`s reliance on a cyclical industry and the utilization of the company’s vessels. Actual results may differ substantially from those expected or projected...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.